|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net loss for the year | |||||
| Net loss from continuing operations | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation expense | |||||
| Unrealized foreign exchange loss (gain) | |||||
| Deferred income tax expense (recovery) | |||||
| Loss from investments accounted for by the equity method | |||||
| Interest on long-term debt and accretion of royalty payable | |||||
| Impairment of long-lived assets (note 9) | |||||
| Change in inventory write-downs to net realizable value (note 7) | |||||
| Gain on sale of investment (note 6) | |||||
| Other income, net | |||||
| Loss on extinguishment | |||||
| Gain on deconsolidation | |||||
| Loss on sale of investment | |||||
| Net loss on sale of assets (notes 10) | |||||
| Impairment of long-term investment | |||||
| Change in bad debt expense | |||||
| Net cash used before working capital changes | |||||
| Changes in working capital | |||||
| Net cash used in operating activities of continuing operations | |||||
| Net cash (used in) provided by operating activities of discontinued operations | |||||
| Investing activities: | |||||
| Purchase of property, plant and equipment | |||||
| Purchase of intangible assets | |||||
| Proceeds on sale of investments | |||||
| Proceeds from sale of operations, net of cash in disposed operations | |||||
| Dividends received from investments accounted for by the equity method (note 8) | |||||
| Proceeds received from holdback receivable (note 6) | |||||
| Capital contributions to investments accounted for by the equity method | |||||
| Net cash provided by (used in) investing activities | |||||
| Net cash provided by (used in) investing activities of continuing operations | |||||
| Net cash used in investing activities of discontinued operations | |||||
| Financing activities: | |||||
| Drawings on operating lines of credit and long-term facilities | |||||
| Repayment of operating lines of credit and long-term facilities | |||||
| Payment of royalty payable | |||||
| Net cash used in financing activities | |||||
| Net cash used in financing activities of continuing operations | |||||
| Net cash (used in) provided by financing activities of discontinued operations | |||||
| Effect of foreign exchange on cash and cash equivalents | |||||
| Net decrease in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of year (including restricted cash) | |||||
| Cash and cash equivalents, end of year (including restricted cash) | |||||
| Less: cash and cash equivalents from discontinued operations, end of year (including restricted cash) | |||||
| Cash and cash equivalents from continuing operations, end of year (including restricted cash) | |||||
| Supplementary information: | |||||
| Interest paid | |||||
| Taxes paid, net of refunds | |||||
| Changes in working capital | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses | |||||
| Accounts payable and accrued liabilities | |||||
| Warranty liability | |||||
| Net cash provided by (used in) operating activities | |||||
Loading...